Suppression of Aβ deposition in brain by peripheral administration of Fab fragments of anti-seed antibody
- 1 September 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 335 (1) , 45-47
- https://doi.org/10.1016/j.bbrc.2005.06.208
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 14 references indexed in Scilit:
- Accelerated Aβ aggregation in the presence of GM1‐ganglioside‐accumulated synaptosomes of aged apoE4‐knock‐in mouse brainFEBS Letters, 2004
- A Seed for Alzheimer Amyloid in the BrainJournal of Neuroscience, 2004
- Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case reportNature Medicine, 2003
- Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesisNature Medicine, 2002
- Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer diseaseNature Medicine, 2002
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- GM1 Ganglioside-Bound Amyloid β-Protein in Alzheimer’s Disease BrainNeurobiology of Aging, 1998
- Amyloid β‐protein (Aβ) associated with lipid molecules: immunoreactivity distinct from that of soluble AβFEBS Letters, 1997
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's diseaseNature Medicine, 1995